Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sohini Mondal

Amgen Stock: Is AMGN Outperforming the Healthcare Sector?

With a market cap of $181.8 billion, Amgen Inc. (AMGN) is a global biotechnology company that discovers, develops, manufactures, and delivers innovative human therapeutics for serious diseases worldwide. Headquartered in Thousand Oaks, California, Amgen serves healthcare providers globally and collaborates with major biopharmaceutical partners to expand and advance its pipeline.

Companies valued at $10 billion or more are generally considered “large-cap” stocks, and Amgen fits this criterion perfectly. Its broad portfolio includes leading treatments across inflammation, oncology, cardiovascular disease, bone health, and rare conditions, with well-known products such as Enbrel, Otezla, Prolia, Repatha, and KYPROLIS.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.